337 related articles for article (PubMed ID: 27226459)
1. Screening for prostate cancer: time to put all the data on the table.
Haines IE; Ablin RJ; Miklos GL
BMJ; 2016 May; 353():i2574. PubMed ID: 27226459
[No Abstract] [Full Text] [Related]
2. Cost-effectiveness of prostate specific antigen screening in the United States: extrapolating from the European study of screening for prostate cancer.
Shteynshlyuger A; Andriole GL
J Urol; 2011 Mar; 185(3):828-32. PubMed ID: 21239021
[TBL] [Abstract][Full Text] [Related]
3. Prostate specific antigen and screening for early prostate cancer.
Davidson P
N Z Med J; 2001 Apr; 114(1129):150. PubMed ID: 11400919
[No Abstract] [Full Text] [Related]
4. Revised status of PSA testing in the early detection and treatment of prostate cancer.
Lamb DS; Delahunt B; Nacey JN
N Z Med J; 2011 Nov; 124(1345):13-5. PubMed ID: 22072161
[No Abstract] [Full Text] [Related]
5. Perspective: Enforce the clinical guidelines.
Roobol M
Nature; 2015 Dec; 528(7582):S123. PubMed ID: 26672782
[No Abstract] [Full Text] [Related]
6. The Melbourne Consensus Statement on the early detection of prostate cancer.
Murphy DG; Ahlering T; Catalona WJ; Crowe H; Crowe J; Clarke N; Cooperberg M; Gillatt D; Gleave M; Loeb S; Roobol M; Sartor O; Pickles T; Wootten A; Walsh PC; Costello AJ
BJU Int; 2014 Feb; 113(2):186-8. PubMed ID: 24206066
[TBL] [Abstract][Full Text] [Related]
7. Cost-effectiveness analysis of PSA-based mass screening: Evidence from a randomised controlled trial combined with register data.
Booth N; Rissanen P; Tammela TLJ; Kujala P; Stenman UH; Taari K; Talala K; Auvinen A
PLoS One; 2019; 14(11):e0224479. PubMed ID: 31689326
[TBL] [Abstract][Full Text] [Related]
8. [International trends and future perspectives on screening for prostate cancer].
Ito K
Nihon Rinsho; 2016 May; 74 Suppl 3():280-5. PubMed ID: 27344742
[No Abstract] [Full Text] [Related]
9. Prostate cancer screening with prostate-specific antigen (PSA) test: a clinical practice guideline.
Tikkinen KAO; Dahm P; Lytvyn L; Heen AF; Vernooij RWM; Siemieniuk RAC; Wheeler R; Vaughan B; Fobuzi AC; Blanker MH; Junod N; Sommer J; Stirnemann J; Yoshimura M; Auer R; MacDonald H; Guyatt G; Vandvik PO; Agoritsas T
BMJ; 2018 Sep; 362():k3581. PubMed ID: 30185545
[No Abstract] [Full Text] [Related]
10. Prostate-Specific Antigen (PSA)-Based Population Screening for Prostate Cancer: An Economic Analysis.
Tawfik A
Ont Health Technol Assess Ser; 2015; 15(11):1-37. PubMed ID: 26366237
[TBL] [Abstract][Full Text] [Related]
11. Summaries for Patients. Screening for cancer.
Ann Intern Med; 2015 May; 162(10):. PubMed ID: 25984869
[No Abstract] [Full Text] [Related]
12. Prostate-specific antigen: a new(ish) study.
Harv Mens Health Watch; 2010 Nov; 15(4):6-8. PubMed ID: 21166115
[No Abstract] [Full Text] [Related]
13. 2008 US Preventive Services Task Force recommendations and prostate cancer screening rates.
Prasad SM; Drazer MW; Huo D; Hu JC; Eggener SE
JAMA; 2012 Apr; 307(16):1692-4. PubMed ID: 22535850
[No Abstract] [Full Text] [Related]
14. Re: Cost-effectiveness of prostate cancer screening: a simulation study based on ERSPC data.
Noordzij MA; Blanker MH
J Natl Cancer Inst; 2015 Jun; 107(6):djv110. PubMed ID: 25888716
[No Abstract] [Full Text] [Related]
15. Re: Cost-Effectiveness of Prostate Cancer Screening: A Simulation Study Based on ERSPC Data.
Taneja SS
J Urol; 2015 Jul; 194(1):113-4. PubMed ID: 26088223
[No Abstract] [Full Text] [Related]
16. Prostate cancer: Prudent practice optimizes screening outcomes.
Auvinen A
Nat Rev Urol; 2016 Jul; 13(7):376-7. PubMed ID: 27215425
[No Abstract] [Full Text] [Related]
17. Long-term consequences of the USPSTF Grade D recommendation for prostate-specific antigen screening.
Joshi SS; Filson CP
Cancer; 2020 Feb; 126(4):694-696. PubMed ID: 31794066
[No Abstract] [Full Text] [Related]
18. Screening for prostate cancer: prostate-specific antigen testing is not effective.
Hitzeman N; Molina M
Am Fam Physician; 2011 Apr; 83(7):802-4. PubMed ID: 21524045
[No Abstract] [Full Text] [Related]
19. Screening for prostate cancer remains controversial.
Stark JR; Mucci L; Rothman KJ; Adami HO
BMJ; 2009 Sep; 339():b3601. PubMed ID: 19778971
[No Abstract] [Full Text] [Related]
20. Summaries for patients. Screening smarter, not harder, for prostate cancer.
Ann Intern Med; 2013 Feb; 158(3):I-30. PubMed ID: 23381056
[No Abstract] [Full Text] [Related]
[Next] [New Search]
